Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tsc2tm1.2Mjg mutation
(0 available);
any
Tsc2 mutation
(77 available)
|
|
|
mortality/aging
|
• most embryos display midgestation lethality similar to published reports
|
embryo
|
• embryos show severe growth retardation (E12.5)
|
growth/size/body
|
• embryos show severe growth retardation (E12.5)
|
Allelic Composition |
Tsc2tm1.2Mjg/Tsc2+
|
|
Genetic Background |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tsc2tm1.2Mjg mutation
(0 available);
any
Tsc2 mutation
(77 available)
|
|
|
renal/urinary system
|
• within first year, lesions consisting of renal cysts are found in some heterozygotes, similar to previous reports of heterozygous mice
|
neoplasm
|
• with first year of life, frank tumors are observed in the kidneys; cystadenomas and renal tumors with abnormal giant cells are observed
|
growth/size/body
|
• within first year, lesions consisting of renal cysts are found in some heterozygotes, similar to previous reports of heterozygous mice
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Pcp2-cre)2Mpin mutation
(1 available)
Tsc2tm1.1Mjg mutation
(1 available);
any
Tsc2 mutation
(77 available)
Tsc2tm1.2Mjg mutation
(0 available);
any
Tsc2 mutation
(77 available)
|
|
|
mortality/aging
|
• 10% of mutants exhibit spontaneous deaths before weaning; cause of death is unknown
|
nervous system
|
• some mutants exhibit seizures
|
|
• Purkinje cells are larger than in wild-type mice
|
|
• mutants exhibit Purkinje cell loss beginning at one month of age which becomes progressively more pronounced over time
• by 7 months of age, mutants lose more Purkinje cells than Tsc2tm1.1Mjg/Tsc2tm1.1Mjg Tg(Pcp2-cre)2Mpin/0 mice
|
behavior/neurological
|
• some mutants exhibit seizures
|